Delivery Method: VIA UPS Reference #: 320-25-72 Product: Drugs Recipient: Recipient Name Mr. Atul B. Mehta Recipient Title President, Co-Chairman, and Co-Founder AACE Pharmaceuticals, Inc. 15 […]

Delivery Method: Via Email Product: Drugs Recipient: Shenzhen Hengkaifeng Commerce and Trade Co., Ltd 3A-18, Wansheng Baihuo, Wanzhong City, Xinniu Community, Minzhi Sub-DistrictLonghua QuShenzhen ShiGuangdong Sheng, […]

In September 2022, the FDA User Fee Reauthorization Act of 2022 (FDAUFRA) was enacted, which included the sixth reauthorization of the Prescription Drug User Fee Act […]

On This Page Date: July 14, 2025 Time: 9:00 a.m. – 2:00 p.m. ET The Food and Drug Administration (FDA or Agency) is announcing a public […]

Summary Company Announcement Date: May 21, 2025 FDA Publish Date: May 22, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description The product contains undeclared […]

Delivery Method: Via Email Reference #: 2851, CMS 654751 Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United […]

For Immediate Release: May 21, 2025 The U.S. Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective and […]

The Medical Device User Fee and Modernization Act (MDUFMA) requires the HHS Secretary to submit an annual report to Congress on the activities and impact of […]

Product: Drugs Recipient: Recipient Name Salim Shah, PhD, JD Recipient Title Founder/President/CEO Sarfez Pharmaceuticals, Inc. 8000 Towers Crescent Drive Suite 1302Vienna, VA 22182United States Issuing Office: […]